INFORMATION BY CANCER TYPE

Lymphoma

Braking Bad: Using Immunotherapy to Fight Hodgkin Lymphoma
BY Heather Millar
By taking the brakes off immune response, immunotherapy empowers the body to fight resistant or recurrent classical Hodgkin lymphoma.
Treatment Options for B Cell Lymphomas Continue to Expand
BY Erik Ness
There’s an enormous — and growing — menu of treatments for B cell lymphomas.
Phase 3 Trial Demonstrates Activity With Adcetris in T-Cell Lymphoma
BY Jason M. Broderick
Adcetris met its primary endpoint in a phase 3 trial for patients with T-cell lymphoma. 
More Than Two Can Tango: Study Finds Many Benefits When Survivors Dance
BY Ellie Leick
A tango program for cancer survivors is showing to have benefits far beyond developing graceful dance moves. 
High Response Rates Seen With Immunotherapy in Early Study of Hodgkin Lymphoma
BY Wayne Kuznar
Data from the KEYNOTE-087 study showed overall response rates of about 70 to 80 percent in three separate groups of relapsed/refractory Hodgkin lymphoma patients.
Resources About Fertility Preservation Lacking for Younger Female Survivors of Cancer
BY Ellie Leick
A recent study showed that for young women who were treated for cancer, the issue of fertility is not adequately addressed. 
FDA Approves Opdivo for Classical Hodgkin Lymphoma
BY Jason M. Broderick
The FDA approved Opdivo (nivolumab) for classical Hodgkin lymphoma (cHL). 
Role Reversal: When Husbands Become Cancer Caregivers
BY Mark Cantrell

 

Men whose partners are diagnosed with cancer may need to learn new strategies to become effective caregivers. 

Survivors of Young-Adult Hodgkin Lymphoma Not Getting All Recommended Checkups
BY Kelly Johnson
Only 30 percent of survivors at high risk for cardiac damage adhered to long-term recommendations including an echocardiogram, electrocardiogram or multigated acquisition scan.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Lymphoma CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.
Adult Non-Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult non-Hodgkin lymphoma.
AIDS-Related Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of AIDS-Related Lymphoma.
Childhood Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood Hodgkin lymphoma.
Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood non-Hodgkin lymphoma.
Primary CNS Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of primary CNS lymphoma.